25535-53-9

N,N'-phthalazine-1,4-diylidenedipyridin-2-amine

3-Piperidinamine,2-(3,5-dibromophenyl)-N-[[2-methoxy-5-(trifluoromethoxy)phenyl]methyl]-, (2R,3R)-rel-

4H-1,3,5-Oxadiazine,2-(3-chloro-4-fluorophenyl)-6-(pentafluoroethyl)-4,4-bis(trifluoromethyl)-

3-Pentanone, 1,5-bis(3,3-dimethylbicyclo[2.2.1]hept-2-yl)-2,4-dimethyl-

4H-1,2,3-Triazolo[4,5-d]pyridazine-4-thione, 1,5-dihydro-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-(1,1-dimethylethyl)-4-ethyl-2-[(4-methyl-1-piperazinyl)methyl]-

3-Piperidinamine,N-[[6-methoxy-3-(trifluoromethyl)-5-isobenzofuranyl]methyl]-2-phenyl-,(2S,3S)-

3-Pentanol, 4-methyl-1-(phenylmethoxy)-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-cyclopentyl-2,4-bis(phenylmethyl)-

4H-1,3,5-Dioxazine, 2,6-diphenyl-4,4-bis(trifluoromethyl)-

4H-1,3,5-Thiadiazine, 2,6-bis(4-methylphenyl)-4,4-bis(trifluoromethyl)-

4H-1,2,4-Triazol-4-amine, 3-azido-5-methyl-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-(1,1-dimethylethyl)-4-ethyl-2-[(4-methoxyphenyl)methyl]-6-methyl-

4H-1,3,5-Oxadiazine,2-(difluoromethyl)-4,4-bis(trifluoromethyl)-6-[3-(trifluoromethyl)phenyl]-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-cyclopentyl-2-(ethoxymethyl)-4-ethyl-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-cyclopentyl-4-ethyl-2-(4-morpholinylmethyl)-

3-Oxazolidinecarboxylic acid,4-butyl-2-(1,1-dimethylethyl)-5-oxo-4-(2-propenyl)-, 2-propenyl ester,(2S,4R)-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-cyclopentyl-4-ethyl-2-[(4-fluorophenyl)methyl]-

3-Pentanone, 1-(4-chlorophenyl)-4-[4-(2-methylpropyl)phenyl]-, (4S)-

4H-[1,2,4]Triazolo[5,1-b]purine-2-carboxylic acid,7-cyclopentyl-4-ethyl-5,6-dihydro-5-oxo-6-(phenylmethyl)-

3-Oxetanemethanol, a-methyl-a-(4-methyl-3-pentenyl)-2-phenyl-,(2R,3R)-rel-

Acetyl chloride, [methyl(tetrahydro-1,1-dioxido-3-thienyl)amino]-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-cyclopentyl-4-ethyl-2-(1H-pyrrol-1-ylmethyl)-

3-Penten-2-one, 4-hydroxy-3-(phenylazo)-

3-Piperidinecarboxamide,N-[trans-4-[(methylsulfonyl)amino]cyclohexyl]-1-(phenylsulfonyl)-, (3S)-

4H-1,2,4-Triazol-4-amine, 3-azido-5-phenyl-

3-Oxetanemethanol, 3-phenyl-, 4-methylbenzenesulfonate

3-Phenanthrenemethanol, 4-bromo-1,2-dihydro-a-2-propenyl-

3-Penten-2-one, 4-[[4-(diphenylphosphinyl)butyl]amino]-, (3Z)-

3-Oxazolidinecarboxylic acid,5-[(4-methoxyphenyl)methylene]-4-oxo-2-thioxo-

1(2H)-Pyrazinecarboxylic acid,4-[(4-fluorophenyl)methyl]-3,4-dihydro-2-(2-methylpropyl)-3-oxo-,phenylmethyl ester, (2S)-

3-Pentanone, 1,1,1,2,4,4,5,5-octafluoro-2-(trifluoromethoxy)-

3-Penten-2-one, 4-hydroxy-, (3E)-

4H-1,2,4-Benzothiadiazine, 7-fluoro-4-(2-fluoroethyl)-, 1,1-dioxide

4H-1,2,4-Triazol-4-amine, 3,5-bis(4-bromophenyl)-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-(1,1-dimethylethyl)-4-ethyl-2-[[4-[2-(4-morpholinyl)ethoxy]phenyl]methyl]-

3-Oxoninol, 9-ethyl-2,3,4,9-tetrahydro-2-(2Z)-2-penten-4-ynyl-,(2S,3R,5Z,7Z,9S)-

25535-53-9 msds

CAS No 25535-53-9 supplier

CASNo 25535-53-9 distributor

CAS # 25535-53-9 manufacturer

CAS Number 25535-53-9 safety

CAS RN 25535-53-9 wholesale

2026-10-14 N,N'-phthalazine-1,4-diylidenedipyridin-2-amine,CAS No.25535-53-9,Formula:C18H12N6. Find Related Products for Bulk Production or Scientific Research